KIMBERLY SIMMS: Open Payments
NPI 1629477088 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,499 in 111 payments from 32 companies in 2025. Trend: 2023 $178 · 2024 $1,399 · 2025 $2,499
Food & beverage: $2,350Education: $150
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 14 | $279 |
| Ascendis Pharma Endocrinology Inc | 5 | $209 |
| Medtronic, Inc. | 6 | $194 |
| Amgen Inc. | 12 | $174 |
| Antares Pharma, Inc. | 7 | $165 |
| AstraZeneca Pharmaceuticals LP | 3 | $159 |
| Novo Nordisk Inc | 10 | $151 |
| RECORDATI_RARE_DISEASES_INC. | 7 | $143 |
| BETA BIONICS, INC. | 4 | $96 |
| Tandem Diabetes Care, Inc. | 4 | $89 |
Products named: Korlym, Yorvipath, MINIMED 780G, XYOSTED, FARXIGA, ISTURISA, TEPEZZA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
